Godavari Biorefineries Investor Presentation: Key Takeaways
Q1 FY27 revenue grew 4.6% to ₹557.9 Cr, but EBITDA fell to ₹2.6 Cr. Performance was pressured by high inventory costs and raw material prices despite strong chemical segment growth.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Q1 FY27 revenue grew 4.6% to ₹557.9 Cr, but EBITDA fell to ₹2.6 Cr. Performance was pressured by high inventory costs and raw material prices despite strong chemical segment growth.
Godavari Biorefineries reported Q1 FY27 total income of ₹559.9 Cr, up 4.9% YoY. Strategy focuses on bio-based chemicals and ethanol capacity expansion.
Godavari Biorefineries delivered a turnaround in FY26, reporting ₹2,000 cr total income and a positive PAT of ₹3.5 cr, driven by operational efficiencies and debt reduction.
Godavari Biorefineries reported FY26 total income of ₹2,000.2 Cr, up 6% YoY, with EBITDA margins stabilizing at 7% as the company shifts towards high-margin bio-based specialty chemicals.